The difference between amplification and expression of Her-2 in breast cancer and relationship with hormone-receptor status

Feng LI,Yun DONG,Hong ZHANG,Yi-zhong FENG

DOI: https://doi.org/10.3969/j.issn.1001-7399.2013.09.003

2013-01-01

Abstract:Purpose To investigate the difference between Her-2 gene amplification and protein expression in breast cancer,and its relationship with hormone-receptor status.Methods With tissue microarray,the differences and correlation between gene amplification and protein expression status of Her-2 in 168 cases of breast invasive ductal cancer was compared,the relationship between gene amplification and protein expression of Her-2 and estrogen receptor(ER),progesterone receptor(PR) and clinicopathologic characteristics was also analyzed.Results Her-2 gene amplification by FISH was observed in 63 of the 168(37.50%) breast cancers.IHC and FISH showed a good coincidence rate in the groups with immunohistochemical scores of 0 /1 +,3 + in breast cancer(Kappa = 0.732,P < 0.01).A low coincidence rate was noted between 2 + and 3 +(Kappa = 0.548,P < 0.01).Her-2 gene amplification was statistically significant correlated with tumor size and lymph node metastasis,while not correlated with the other clinicopathologic features.Additionally,Her-2 gene negatively correlated with the expression of ER(r = 0.161,P < 0.05).Conclusion As an independent prognostic marker,Her-2 gene amplification by FISH has a good coincidence rate in the groups with immunohistochemical scores of 0 /1 +,3 + in breast cancer,while patients with stain scores of 2 + should be testified by FISH.Her-2 gene amplification was statistically significant correlated with tumor size,lymph node metastasis and the expression of ER.